Glossary

Wegovy

Updated March 29, 2026

Wegovy is a weekly semaglutide injection approved for chronic weight management. It reaches a higher maximum dose than Ozempic (2.4mg vs. 2mg) and follows a 16-week titration schedule designed for weight loss rather than blood sugar control. For people who train, Wegovy's strong appetite suppression makes calorie deficit adherence easier, but the 16-week dose ramp means your nutrition strategy needs to evolve as appetite effects intensify at each step. If you stop Wegovy after a successful cut, the appetite and portion-size rebound can erase progress faster than most people expect. Read How to Stop GLP-1s Without Rapid Fat Regain for the withdrawal evidence and the off-ramp strategy.

Quick reference

ItemDetail
Active ingredientsemaglutide
Medication familyGLP-1 receptor agonist
Formweekly subcutaneous injection
Titration schedule0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), 2.4mg (week 17+)
When appetite effects startmost people notice reduced hunger within 1-2 weeks, with the strongest effects at 1mg and above
Clinical indicationchronic weight management (FDA-approved for BMI 30+ or 27+ with comorbidity)

What Wegovy's titration means for training people

Each dose step increases appetite suppression, which means your nutrition strategy needs to adapt every 4 weeks during the ramp. The biggest adjustment window is usually the jump from 1mg to 1.7mg, where many people experience a sharp drop in hunger and increased nausea.

Dose phaseTypical appetite effectNutrition priority
0.25-0.5mg (weeks 1-8)mild to moderate hunger reductionbuild meal templates and establish protein tracking habits before suppression gets strong
1mg (weeks 9-12)noticeable appetite reduction, food noise decreaseslock in 1.2-1.6 g/kg protein daily, establish pre/post workout meals
1.7mg (weeks 13-16)strong suppression, nausea risk increasesswitch to smaller, more frequent meals (4-5 per day), protect pre-workout carbs
2.4mg (week 17+)strongest suppression, some meals feel difficultsimplify protein formats (shakes, yogurt, deli turkey), use default meal templates to hit minimums

Physique-first cut protocol

Control pointSpecific targetsPractical examplesWhat it prevents
Deficit sizing15-25% below maintenance (300-500 cal/day)if maintenance is 2,200 cal, target 1,700-1,900 calstrength loss and rebound hunger
Protein floor1.2-1.6 g/kg daily, 25-35g per meal4 oz chicken (~35g), 6 oz salmon (~34g), 1 cup Greek yogurt (~20g), 1 scoop whey (~25g)lean mass loss during rapid appetite suppression
Training consistency3-4 resistance sessions per week, reduce volume before frequencysquat, bench, row, deadlift or variations"losing weight but looking smaller" outcomes
Meal structure3-4 meals daily with protein-first approach, templates for low-appetite daysprep containers: chicken + rice + greens, turkey wraps, Greek yogurt + granolaskipped meals and micronutrient collapse

Side-effect management specific to Wegovy

IssueWhen it typically peaksFoods and actions that help
Nauseafirst 3-5 days after each dose increase, worst at 1.7mg stepeat slowly (15-20 min per meal), choose bland foods (plain rice, toast, broth, cold yogurt), avoid greasy foods, keep meals under 400 cal until tolerance stabilizes
Constipationongoing if fiber and fluids are lowramp fiber by 3-5g per week (ground flaxseed, chia seeds, cooked vegetables), add 16-24 oz water daily
Food aversion toward proteincommon at 2.4mg when dense textures feel unappealingswitch to simpler protein formats (shakes, Greek yogurt, deli turkey, egg whites), keep portions small and consistent

Monitoring and adjustment

SignalWhat it meansNext move
Weight down but waist unchanged over 2+ weekslikely water noise or hidden intake drifthold steady, audit logging accuracy and sodium/hydration pattern
Strength down across 2+ sessionsunder-fueling or recovery failureraise intake by 200-300 cal (add one protein-rich snack), audit sleep
Plateau over 2+ weeks with good adherencenormal adaptation or hidden driftfollow weight loss plateau checks before changing targets, use a 14-day trend window
Losing more than 1.5 lb per week consistentlydeficit may be too aggressive for lean mass preservationraise intake by 200-300 cal and recheck in 2 weeks

Safety and escalation thresholds

Signal patternWhy it mattersNext step
Severe abdominal pain with persistent vomitingpancreatitis or gallbladder complication riskurgent clinical evaluation
Persistent inability to hydrate or eat enough to functionunder-fueling riskpause aggressive fat loss and seek medical guidance
Pregnancy or trying to conceivemedication safety constraints (stop Wegovy at least 2 months before planned conception)clinician-led plan only

Related

Semaglutide

Semaglutide is a GLP-1 receptor agonist that reduces appetite and stabilizes blood sugar by mimicking the GLP-1 hormone your gut produces after eating

GLP-1 Receptor Agonist

A GLP-1 receptor agonist is a prescription medication that mimics the GLP-1 hormone your gut produces after eating

Ozempic

Ozempic is a weekly semaglutide injection approved for type 2 diabetes, where weight loss occurs as a secondary effect